BSE filing, NSE: KOTAKBANK. Summary written from the filing by ALFA Finder's alert engine.
Kotak Mahindra Bank Ltd: key numbers
- Share price
- ₹440.00
- Market cap
- ₹4,37,707 Cr
- Revenue (annual)
- ₹69,781 Cr
- Net profit (annual)
- ₹19,288 Cr
- P/E (TTM)
- 20.4×Sector 19.7×
- Promoter holding
- 25.87%+0.00% QoQ
- FII holding
- 24.65%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kotak Mahindra Bank Ltd
All →Kotak Mahindra Bank Earnings Call Transcript: Key Takeaways
Kotak delivered strong PAT growth led by a massive FCNR(B) deposit mobilization, which provided significant liquidity for future deployment. Management is prioritizing responsible growth while navigating a rising interest rate environment.
- Call
- Guides 19% growth
Kotak Mahindra Bank Other Announcement
Kotak Mahindra Bank filed its Regulation 54(3) security cover statement as at 30 September 2026. It is a routine compliance certificate with no stated cover ratio.
Kotak Mahindra Bank Management Change
Kotak Mahindra Bank named Anup Kumar Saha MD & CEO from January 2027. Ashu Suyash re-appointed as Independent Director for three years.
- Execution
- Three years, 1 January 2027 onward (MD & CEO); 24 January 2027 to 23 January 2030 (Independent Director)
Kotak Mahindra Bank Investor Presentation: Key Takeaways
Q2FY27 consolidated PAT ₹5,645 cr (+26% YoY); Bank PAT ₹4,212 cr (+29%). NII +16%, credit cost 0.35% (0.79%), bank ROE 11.65%. Strategy: 'Transforming for scale' via segments, product businesses, tech/AI.
Kotak Mahindra Bank Results Update
Kotak Mahindra Bank's media release reports Q2FY27 standalone PAT of ₹4,212 crore, up 29% YoY. Consolidated PAT rose 26% YoY to ₹5,645 crore.
Kotak Mahindra Bank Financial Results
Kotak Mahindra Bank's board approved unaudited consolidated and standalone results for the quarter and half-year ended September 2026. Joint auditors issued unmodified review conclusions on the statements.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date